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Abstract We proposed to assess serum antioxidant vitamins
and magnesium (Mg) levels in patients with fibromyalgia
(FM) in comparison to healthy controls. Additionally, the
association between the serum antioxidant vitamins, magne-
sium levels, and clinical parameters in FM patients was also
investigated. Forty female patients, aged between 30 and
50 years, were diagnosed with FM according to ACR-1990
criteria, and 40 healthy controls were included in the present
study. Socio-demographic characteristics of participants,
accompanying symptoms, and number of tender points
(TP) of the patients were recorded. The intensity of pain
was measured using the visual analogue scale (VAS). The
functional status and depression levels were evaluated with
Fibromyalgia Impact Questionnaire (FIQ) and Beck Depres-
sion Inventory (BDI), respectively. Serum vitamins A, C, and
E and Mg levels were measured. There were no significant
differences in the levels of vitamins A, C, and E and Mg
between control subjects and patients with fibromyalgia
(p>0.05). In addition, no statistically significant correlations
were found between mean levels of serum vitamins A, C,
and E, and Mg and number of TP, scores of VAS, FIQ, and
BDI in patients with FM (p>0.05). According to the results
of this study, it was asserted that other complex mechanism
may play an important role in the pathophysiology of FM
without plasma antioxidant vitamins and Mg levels.
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Introduction
Reactive oxygen species (ROS) are highly reactive
chemical species with an unpaired electron and formed
by catalyzing transition metals like iron, copper, or
manganese [1]. ROS are formed in oxidative processes
that normally occur at relatively low levels in all cells and
tissues. Under normal conditions, the concentrations of
ROS are kept under strict control by the activity of a
complex defense system including enzymes and non-
enzymatic species. In contrast, high doses and/or inadequate
removal ROS results in oxidative stress, which may cause
severe metabolic malfunctions and damage to biological
macromolecules [2, 3]. In recent years, a great number of
studies have investigated the possible role of oxidative stress
in the etiopathogenesis of various rheumatological disease
including rheumatoid arthritis, ankylosing spondylitis, and
chronic fatigue syndrome [4–6].
Fibromyalgia (FM) is rheumatic disorder characterized
by musculoskeletal pain, stiffness, and tenderness of
specific anatomic sites [7]. The etiology of FM is still
unknown and also it is associated with many factors and
predictors [8, 9]. Oxidative stress and/or an imbalance of
trace element status may play an important role in the
pathophysiology of FM [10–13].
Vitamins A, E, and C are known to be a powerful non-
enzymatic antioxidant [14, 15]. Vitamins A and E are
essential fat-soluble vitamins. They are the major chain-
breaking antioxidants in body tissues and are considered the
first line defense against lipid peroxidation, protecting cell
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activity [16–18]. Vitamin C is the major water-soluble
vitamin. It, as well as being a free radical scavenger, also
transforms vitamin E to its active form [19]. Magnesium
(Mg) is a trace element, which plays a considerable role in
ATP synthesis, and it is important for adequate muscle
metabolism [20]. In recent years, serum Mg levels have
been researched to reveal etiopathogenesis of patients with
FM [21, 22].
In literature, there have been few studies that investigate
the role of antioxidant vitamins and Mg in the etiopatho-
genesis of FM, and their results are contradictory [21–24].
We proposed to assess serum antioxidant vitamins and Mg
levels in patients with FM in comparison to healthy
controls. The association between the serum antioxidant
vitamins, Mg levels, and clinical parameters in FM patients
was also investigated.
Materials and methods
Forty (n=40) premenopausal women who met the 1990
American College of Rheumatology (ACR) criteria for the
diagnosis of FM [25] were enrolled in the study. Forty
(n=40) age, sex, geographic location matched demographi-
cally similar healthy premenopausal women were selected as
controls. Informed consent was obtained from all subjects,
and the study protocol was approved by the local ethics
committee. Routine blood tests, sedimentation rate, liver and
kidney blood tests, thyroid hormone concentration, and sex
hormone profiles of the patients and controls were
evaluated. The criteria for exclusion were severe chronic
diseases (e.g., chronic renal/liver failure, hepatitis), other
rheumatic diseases, severe neuropsychiatric, endocrino-
logic disorders (e.g., diabetes mellitus, hypo, or hyper-
thyroidism), painful or disabling medical conditions,
neuropathic pain disease, and undesired habits (e.g.,
smoking, alcohol, etc.). Neither patients nor controls
were using any medicine that effects the serum antioxidant
vitamins and Mg levels and statin. None of the patients was
under the treatment of antidepressants and analgesics and
were only included if they had stopped using them at least
4 weeks before study.
The demographic features [age, height, body weight, body
mass index (BMI), duration of disease] and accompanying
symptoms [fatigue, headache, dyspnea, pollakiuria, morning
stiffness (generalized stiffness of the muscles and joints after
waking up in the morning especially in the hands, arms, legs,
and feet lasting for 45 min or longer), sleep disorders, anxiety,
dysmenorrhea, Raynaud’s-like symptoms, and irritable bowel
syndrome] of the patients were documented. The patients
were examined in terms of widespread chronic pain, number
of tender points (TP), functional capacity, and depression
level. Severity of pain was evaluated using 10 cm visual
analogue scale (VAS). Higher scores of VAS indicate more
severe symptoms [26]. TP defined by ACR were determined
by applying a 4-kg pressure with the thumb on specific body
points and the number of TP recorded. Tender point
examination was carried out by the exertion of a uniform
amount of manual finger pressure, until fingernail bed
blanches. Functional capacity in daily living activities was
e v a l u a t e db yT u r k i s hv e r s i o no ff i b r o m y a l g i ai m p a c t
questionnaire (FIQ) [27]. Depression rate was assessed by
Beck Depression Inventory (BDI).The test consists of 21
questions scaled in a Likert format. The higher score shows
increased depression of subjects [28]. The score over 17 was
accepted to be a sign of depression.
For laboratory investigations, venous blood was taken
from the cubital vein into plain and anticoagulation tubes
containing sodium EDTA and protected against light, after
an overnight fast and with all morning medication omitted.
After serum and plasma samples were separated by
centrifugation at 1,500×g for 10 min at +4°C, the serum
samples were used for immediate Mg analysis, while the
plasma samples were stored in a freezer (−70°C) until the
time of vitamin assay analysis. Mg levels were measured with
colorimetric method (Magon/Xylidyl blue) by Roche Modular
equipment. Plasma vitamins A, E, and C levels were measured
with High Performance Liquid Chromatography (HPLC)
system (Agilent Technologies, Waldbronn, Germany) using
thecommercialkits(ChromsytemsInstrumentsandChemicals
GmbH, München, Germany).
Statistical analyses
Statistical Package for Social Sciences (SPSS Inc., Chicago,
IL, USA) software, version 11.0 for Windows, was used for
all statistical analyses. Normality analyses were made with
the Kolmogorov–Smirnov test. Data showing a normal
distribution were expressed with mean value±standard
deviation. To test for statistical differences between two
groups, Student’s t tests were used. For correlation between
results, the Pearson’s correlation coefficient was performed.
The sociodemographical characteristics of the groups were
evaluated by chi-square test. p values less than 0.05 were
considered statistically significant.
Results
Demographic and clinical characteristics of patients with
FM and controls are shown in Table 1. Demographic
characteristics were statistically similar in groups (p>0.05).
TP number, VAS (pain) score, BDI score, and FIQ score
were significantly (p<0.001) higher in patients with FM
than controls. The most frequently encountered symptoms
1040 Clin Rheumatol (2011) 30:1039–1043accompanying patients with FM were fatigue (100%) and
anxiety (95%), as shown in Table 1.
The mean concentrations of thyroid hormones (thyroid-
stimulating hormone—TSH, free triiodothyronine—FT3,
free thyroxine—FT4), sex hormones (follicle-stimulating
hormone—FSH, Luteinising hormone—LH, estradiol—
E2), vitamins A, C, and E and Mg in plasma of patients
with FM and controls are shown in Table 1. There were no
significant differences between groups according to TSH,
FT3, FT4, FSH, LH, and E2 (p>0.05). The mean values of
vitamins A, C, and E in patients and controls were 1.46 and
1.25, 3.69, and 3.70, 24.39, and 21.98 mmol/L, respectively.
Patients and controlsbothhada meanMglevel of0,87mmol/
L. There were no significant differences in the levels of
vitamins A, C, and E and Mg between control subjects and
patients with FM (p>0.05). In addition, no statistically
significant correlations were found between mean levels of
serum vitamins A, C, and E and Mg and number of TP,
scores of VAS (pain), FIQ, and BDI in patients with FM
(p>0.05; Table 2).
Discussion
The etiology and pathogenesis of FM are not clearly
understood. Recent studies have demonstrated that oxida-
tive stress and serum trace elements may have a role in the
pathophysiology of FM [10, 11]. For the purpose to support
the etiopathogenesis of FM, we assessed serum antioxidant
vitamins, Mg trace element levels in patients with FM in
Characteristics Fibromyalgia (n=40)
mean±SD
Control (n=40)
mean±SD
p value Frequency
(n,% )
Demographic characteristics
Age (years) 33.61±7.55 31.67±7.03 0.134
Height (cm) 161.9±5.30 163.2±6.09 0.398
Body weight (kg) 61.4±4.91 60.6±6.06 0.554
BMI (kg/m
2) 23.42±1.58 22.79±1.59 0.076
Clinical characteristics
Tender point number 13.95±1.75 1.68±1.82 0.001
Duration of disease (years) 4.25±3.11 ––
VAS pain score (cm) 8.00±1.48 0.35±0.77 0.001
FIQ score 61.32±9.23 4.94±4.11 0.001
BDI score 11.23±4.87 2.10±2.48 0.001
Laboratory measurements
FT4 (ng/mL) 0.99±0.14 1.08±0.16 0.078
FT3 (pg/mL) 2.65±0.44 2.83±0.36 0.063
TSH (μIU/mL) 1.62±0.98 1.66±0.94 0.826
FSH (mU/ml) 8.14±9.52 9.44±18.99 0.711
LH (m IU/mL) 5.63±4.23 6.27±6.65 0.620
E2 (pg/mL) 78.55±53.69 103.23±84.13 0.108
Vitamin A (mmol/L) 1.46±0.47 1.25±0.26 0.119
Vitamin C (mmol/L) 3.69±2.20 3.70±2.33 0.974
Vitamin E (mmol/L) 24.39±5.25 21.98±5.48 0.072
Magnesium (mmol/L) 0.87±0.07 0.87±0.08 0.977
Signs and symptoms
Fatigue 40 (100)
Anxiety 38 (95)
Sleep disorders 37 (92.5)
Headache 37 (92.5)
Morning stiffness 33 (82.5)
Irritable bowel syndrome 27 (67.5)
Dyspnea 24 (60)
Dysmenorrhea 21 (52.5)
Pollakiuria 13 (32.5)
Raynaud’s-like symptoms 8 (20)
Table 1 Demographic, clinical
characteristics, laboratory
measurements, and signs
and symptoms of patients
with fibromyalgia and
control
p value is significant when
<0.05
BMI body mass index,
FIQ Fibromyalgia Impact
Questionnaire, FSH
follicle-stimulating
hormone, VAS visual
analogue scale, BDI Beck
Depression Inventory, LH
Luteinising hormone,
TSH thyroid-stimulating
hormone, ST3 free
thyroxine, ST4 free
triiodothyronine, E2
estradiol, mean ± SD
mean±standard deviation
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tion between the serum antioxidant vitamins, Mg levels,
and clinical parameters in FM patients was also investigated.
As a result, there were no significant differences in the levels
of vitamins A, C, and E and Mg between control subjects and
patients with FM. In addition, no correlations were found
between levels of serum vitamins A, C, and E and Mg and
number of TP, severity of pain, functional capacity, and
depression in patients with FM.
The increase in toxic ROS and decrease in antioxidant
defense mechanism are defined as oxidative stress and
contribute to local tissue injury, organ dysfunction, and
many disorders including inflammation, carcinogenesis,
atherosclerosis, and neurodegenerative diseases [3]. The
role of free radical-mediated oxidative damage was inves-
tigated in the etiopathogenesis of FM. Fassbenger and
Wegner [29] reported that muscle tender points in FM result
from local hypoxia. Lund et al. [30] indicated abnormal
oxygen pressure at the muscle surface above trigger points.
Another study showed microcirculatory disturbances in
tender points [31]. These studies lead to the importance on
oxidative stress as a basic pathologic process in FM.
In literature, there are studies on enyzmatic antioxidant
capacity of plasma (superoxide dismutase, catalase, glutathione
peroxidase, adenosine deaminase) in patients with FM
[10, 32, 33]. These study findings may support the hypothesis
of FM as an oxidative disorder. Vitamins A, E, and C are
known to be a powerful non-enzymatic antioxidant [14, 15].
To our knowledge, there are two studies on vitamins A and E
concentrations and one publication on vitamin C concentra-
tion in blood of patients with FM [23, 24]. Eisinger et al. [24]
measured plasma vitamins A and E concentrations in 28
patients with FM and 20 age-matched controls, and they
found that there were no statistically significant changes in
any of the vitamin concentrations in the patients. In contrast,
Akkus et al. [23] showed that vitamins A and E levels in 30
female patients with FM were lower than in 30 age- and sex-
matched controls and plasma vitamin C concentrations of
patients did not change. They reportedthatplasma vitaminsA
and E concentrations in the patients may be used as a result of
their role action on radical inhibition. In the present study,
there were no significant differences in the levels of plasma
vitamins A, C, and E between control subjects and patients
with fibromyalgia. The study population of the study of
Akkus et al. is similar to that of our study, but their results had
considerable difference. They used spectrophotometric
analysis, but we analyzed our data with HPLC. Since we did
not use the same method, the results cannot be comparable.
There are little and paradoxical data, so more clinical trials are
needed to explore the issue.
The role of Mg deficiency in patients with FM is
controversial. Similar to the current study in past years,
Prescott et al. [34] and Rosborg et al. [22] reported that
serum Mg level of patients with FM were normal. In
contrast, Sendur et al. [21] reported that Mg levels in
plasma of patients with FM were lower than control. In
another study by Eisinger et al. [12], the erythrocyte Mg
level was slightly lower in patients with FM. Abraham and
Flechas [13] also found that Mg deficiency plays a possible
role in mechanism of pain in FM. They thought this was
related to the role of Mg in the production of ATP. The
present investigation gave no support for the hypothesis
that Mg deficiency in plasma plays a significant role in the
development of FM.
Pain is a major symptom of FM. The number of TP is
also important [7]. Depression is usually accompanying
with FM [35]. We thought that levels of antioxidant vitamin
and Mg might affect these symptoms. We investigated this
issue but found no correlation between severity of pain,
functional capacity, number of TP, levels of depression, and
antioxidant vitamin and Mg levels. In literature, we
encountered no study investigating the correlation between
antioxidant vitamins and clinical parameters. The associa-
tion between serum Mg level and clinical parameters was
investigated only by Sendur et al. [21]. They found no
statistically significant association between Mg levels and
clinical parameters (pain, number of TP, functional capacity,
disease duration, morning stiffness).
The major limitation of the current study is the limited
number of patients who were all women. Future studies
should include larger populations and both sexes. Previous
studies of FS patients in our country had similar results of age
and duration of disease as in the current study [10, 21, 23].
According to the results of this study, it was asserted that
other complex mechanism may play an important role in
Table 2 Correlation between serum antioxidant vitamins, magnesium
levels and clinical findings in patients with fibromyalgia
Vitamin A Vitamin C Vitamin E Magnesium
Tender point number
r −0.110 −0.170 −0.150 0.121
p 0.499 0.294 0.357 0.457
VAS pain score (cm)
r −0.195 0.081 −0.311 0.165
p 0.228 0.621 0.051 0.309
FIQ score
r −0.083 −0.115 −0.171 0.014
p 0.611 0.481 0.291 0.934
BDI score
r 0.177 −0.098 −0.246 −0.032
p 0.276 0.548 0.126 0.844
p value is significant when <0.05
VAS Visual Analogue Scale, FIQ Fibromyalgia Impact Questionnaire,
r Pearson’s correlation coefficient, BDI Beck Depression Inventory
1042 Clin Rheumatol (2011) 30:1039–1043the pathophysiology of FM without plasma antioxidant
vitamins and Mg levels. These findings justify further
researches to explore the effect of antioxidant vitamins and
Mg trace element in FM.
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